Definitive Contract 75N93023C00045
Award Date 9/30/23
Potential Completion Date 9/29/26
Potential Value $4.7M
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
New Orleans, LA 70112, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
24
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services, to the Administrators of Tulane Educational Fund, the parent organization of Tulane University, a private research university in New Orleans, Louisiana. The $150,000 contract is for animal models of infectious diseases research, as part of NIAID's broader Animal Models of Infectious Diseases 2010-2017 master...
- This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to The Administrators of Tulane Educational Fund, doing business as Tulane University. The contract is a delivery order under the "Simian Vaccine Evaluation Units 2013-2020" indefinite delivery contract, with a ceiling value of $9,035,728.24 and a completion date of April 30, 2022. The contract is for "Simian...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $9,705,349.83 Definitive Contract to The Administrators of the Tulane Educational Fund, doing business as Tulane University, a private non-profit university in New Orleans, Louisiana. This non-severable base period contract runs from September 30, 2018 to September 29, 2019, with a completion date of July 14, 2024. The contract has a Cost No Fee pricing type...
- This is a delivery order award to The Administrators Of Tulane Educational Fund, doing business as Tulane University, under the National Institute of Allergy and Infectious Diseases' (NIAID) Simian Vaccine Evaluation Units master contract. The $1,796,343 award is for a study titled "CONDUCT STUDY P217" with a period of performance through October 30, 2026. The contract does not have a set-aside designation. As a comprehensive research university, Tulane University has extensive...
- This is a delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to The Administrators of Tulane Educational Fund, doing business as Tulane University. The $150,969.93 award provides administrative and technical support for ongoing studies and the final transition under the Simian Vaccine Evaluation Units program, which is a major program code associated with this contract. The...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $645,369.00 delivery order to The Administrators of the Tulane Educational Fund, doing business as Tulane University, on August 5, 2019. The award, which is not set aside, is for the Conduct Study P209 under the Simian Vaccine Evaluation Units 2013-2020 master contract vehicle. Tulane University, a private non-profit university located in New...
- The National Institute of Allergy and Infectious Diseases awarded a delivery order valued at $2.18M to The Administrators of Tulane Educational Fund (doing business as Tulane University) on April 1, 2020, to conduct Study P223. This cost-plus-no-fee delivery order falls under the Simian Vaccine Evaluation Units indefinite delivery contract and is scheduled for completion by December 24, 2027. The work will be performed in New Orleans, Louisiana, where Tulane maintains its National Primate...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $16.5 million cost-no-fee definitive contract to The Administrators of Tulane Educational Fund, doing business as Tulane University, for novel mucosal vaccine approaches for pneumonia. The award, made on September 23, 2022, extends through March 6, 2027, and will be performed in New Orleans, Louisiana. This contract was not subject to a set-aside designation. The work responds to NIAID's Broad Agency Announcement seeking...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $3,041,214 delivery order contract to Tulane University to conduct a study titled "CONDUCT STUDY P214". This contract is under NIAID's Simian Vaccine Evaluation Units (SVEUS) Indefinite Delivery Contract (IDC), a $146,300,000 multiple-award vehicle for preclinical research support services. The contract has a period of performance through July 23, 2026 and does not contain a set-aside designation. Tulane...
- This $1,422,288.62 federal delivery order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the Administrators of Tulane Educational Fund, doing business as Tulane University, a private university in New Orleans, Louisiana. The contract is for "Simian Vaccine Evaluation Units" and has an ultimate completion date of June 30, 2020. It is a cost-no-fee contract issued under a...